Alles VV, Bottazzi B, Peri G, Golay J, Introna M, Mantovani A (1994) Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes. Blood 84:3483–3493
PubMed
CAS
Google Scholar
Bottazzi B, Inforzato A, Messa M, Barbagallo M, Magrini E, Garlanda C, Mantovani A (2016) The pentraxins PTX3 and SAP in innate immunity, regulation of inflammation and tissue remodelling. J Hepatol 64:1416–1427. https://doi.org/10.1016/j.jhep.2016.02.029
Article
PubMed
PubMed Central
CAS
Google Scholar
Bozza S, Campo S, Arseni B, Inforzato A, Ragnar L, Bottazzi B, Mantovani A, Moretti S, Oikonomous V, De Santis R, Carvalho A, Salvatori G, Romani L (2014) PTX3 binds MD-2 and promotes TRIF-dependent immune protection in Aspergillosis. J Immunol 193:2340–2348. https://doi.org/10.4049/jimmunol.1400814
Article
PubMed
CAS
Google Scholar
Breviario F, d’Aniello EM, Golay J, Peri G, Bottazzi B, Bairoch A, Saccone S, Marzella R, Predazzi V, Rocchi M, Della Valle G, Dejana E, Mantovani A, Introna M (1992) Interleukin-1-inducible genes in endothelial cells. J Biol Chem 267:22190–22197
PubMed
CAS
Google Scholar
Chu SH, Park JH, Lee MK, Jekal Y, Ahn KY, Chung JY, Lee DH, Kim ES, Naruse M, Im JA, Kong D, Chung CH, Lee JW, Chung KM, Kim YB, Jeon JY (2012) The association between pentraxin 3 and insulin resistance in obese children at baseline and after physical activity intervention. Clin Chim Acta 413:1430–1437. https://doi.org/10.1016/j.cca.2012.06.002
Article
PubMed
CAS
Google Scholar
Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35:1381–1395. https://doi.org/10.1249/01.MSS.0000078924.61453.FB
Article
PubMed
Google Scholar
Deban L, Russo RC, Sironi M, Moalli F, Scanziani M, Zambelli V, Cuccovillo I, Bastone A, Gobbi M, Valentino S, Doni A, Garlanda C, Danese S, Salvatori G, Sassano M, Evangelista V, Rossi B, Zenaro E, Constantin G, Laudanna C, Bottazzi B, Mantovani A (2010) Regulation of leukocyte recruitment by the long pentraxin PTX3. Nat Immunol 11:328–334. https://doi.org/10.1038/ni.1854
Article
PubMed
CAS
Google Scholar
Escobar-Morreale H, Martínez-García M, Montes-Nieto R, Fernández-Durán E, Temprano-Carazo S, Luque-Ramírez M (2017) Effects of glucose ingestion on circulating inflammatory mediators: Influence of sex and weight excess. Clin Nutr 36:522–529. https://doi.org/10.1016/j.clnu.2016.01.015
Article
PubMed
CAS
Google Scholar
Fattori E, Cappelletti M, Costa P, Semtto C, Cantoni L, Careui M, Faggioni R, Fantuzzi G, Ghezzi P, Poli V (1994) Defective inflammatory response in interleukin 6-deficient mice. J Exp Med 180:1243–1250
Article
PubMed
CAS
Google Scholar
Fernando MR, Reyes JL, Iannuzzi J, Leung G, McKay DM (2014) The pro-inflammatory cytokine, interleukin-6, enhances the polarization of alternatively activated macrophages. PLoS One 9:e94188. https://doi.org/10.1371/journal.pone.0094188
Article
PubMed
PubMed Central
CAS
Google Scholar
Gleeson M, Bishop NC, Stensel DJ, Lindley MR, Mastana SS, Nimmo MA (2011) The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol 11:607–615. https://doi.org/10.1038/nri3041
Article
PubMed
CAS
Google Scholar
Huang C-J, Webb HE, Beasley KN, McAlpine DA, Tangsilsat SE, Acevedo EO (2014) Cardiorespiratory fitness does not alter plasma pentraxin 3 and cortisol reactivity to acute psychological stress and exercise. Appl Physiol Nutr Metab 39:375–380. https://doi.org/10.1139/apnm-2013-0297
Article
PubMed
CAS
Google Scholar
Imamura M, Kawasaki T, Savchenko AS, Ohashi R, Jiang S, Miyamoto K, Ito Y, Iwanari H, Sagara M, Tanaka T, Hamakubo T, Kodama T, Uchiyama M, Naito M (2007) Lipopolysaccharide induced expression of pentraxin 3 in human neutrophils and monocyte-derived macrophages. Cell Immunol 248:86–94. https://doi.org/10.1016/j.cellimm.2007.09.003
Article
PubMed
CAS
Google Scholar
Jaillon S, Peri G, Delneste Y, Frémaux I, Doni A, Moalli F, Garlanda C, Romani L, Gascan H, Bellocchio S, Bozza S, Cassatella MA, Jeannin P, Mantovani A (2007) The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. J Exp Med 204:793–804. https://doi.org/10.1084/jem.20061301
Article
PubMed
PubMed Central
CAS
Google Scholar
Jenny NS, Arnold AM, Kuller LH, Tracy RP, Psaty BM (2009) Associations of pentraxin 3 with cardiovascular disease and all-cause death: The cardiovascular health study. Arterioscler Thromb Vasc Biol 2009 29:594–599. https://doi.org/10.1161/ATVBAHA.108.178947
Article
PubMed
PubMed Central
CAS
Google Scholar
Kahn S, Hull R, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840–846. https://doi.org/10.1038/nature05482
Article
PubMed
CAS
Google Scholar
Lancaster GI, Langley KG, Berglund NA, Kammoun HL, Reibe S, Estevez E, Weir J, Mellett NA, Pernes G, Conway JRW, Lee MKS, Timpson P, Murphy AJ, Masters SL, Gerondakis S, Bartonicek N, Kaczorowski DC, Dinger ME, Meikle PJ, Bond PJ, Febbraio MA (2018) Evidence that TLR4 is not a receptor for saturated fatty acids but mediates lipid-induced inflammation by reprogramming macrophage metabolism. Cell Metab 27(5):1096–1110.e5
Article
PubMed
CAS
Google Scholar
Maina V, Cotena A, Doni A, Nebuloni M, Pasqualini F, Milner CM, Day AJ, Mantovani A, Garlanda C (2009) Coregulation in human leukocytes of the long pentraxin PTX3 and TSG-6. J Leukoc Biol 86:123–132. https://doi.org/10.1189/jlb.0608345
Article
PubMed
PubMed Central
CAS
Google Scholar
Mauer J, Chaurasia B, Goldau J, Vogt MC, Ruud J, Nguyen KD, Theurich S, Hausen AC, Schmitz J, Brönneke HS, Estevez E, Allen TL, Mesaros A, Partridge L, Febbraio MA, Chawla A, Wunderlich FT, Brüning JC (2014) Interlukin-6 signaling promotes alternative macrophage activation to limit obesity-associate insulin resistance and endotoxemia. Nat Immunol 15:423–430. https://doi.org/10.1038/ni.2865
Article
PubMed
PubMed Central
CAS
Google Scholar
Miyaki A, Maeda S, Otsuki T, Ajisaka R (2011) Plasma pentraxin 3 concentration increases in endurance-trained men. Med Sci Sports Exerc 43:12–17. https://doi.org/10.1249/MSS.0b013e3181e84bce
Article
PubMed
CAS
Google Scholar
Miyaki A, Maeda S, Choi Y, Akazawa N, Tanabe Y, Ajisaka R (2012) Habitual aerobic exercise increases plasma pentraxin 3 levels in middle-aged and elderly women. Appl Physiol Nutr Metab 37:907–911. https://doi.org/10.1139/h2012-069
Article
PubMed
CAS
Google Scholar
Miyaki A, Choi Y, Maeda S (2014) Pentraxin 3 production in the adipose tissue and the skeletal muscle in diabetic-obese mice. Am J Med Sci 347, 228–233. https://doi.org/10.1097/MAJ.0b013e31828341af
Article
PubMed
Google Scholar
Nakajima T, Kurano M, Hasegawa T, Takano H, Iida H, Yasuda T, Fukuda T, Madarame H, Uno K, Meguro K, Shiga T, Sagara M, Nagata T, Maemura K, Hirata Y, Yamasoba T, Nagai R (2010) Pentraxin3 and high-sensitive C-reactive protein are independent inflammatory markers released during high-intensity exercise. Eur J Appl Physiol 110:905–913. https://doi.org/10.1007/s00421-010-1572-x
Article
PubMed
CAS
Google Scholar
Norata GD, Marchesi P, Pulakazhi Venu VK, Pasqualini F, Anselmo A, Moalli F, Pizzitola I, Garlanda C, Mantovani A, Catapano AL (2009) Deficiency of the long pentraxin ptx3 promotes vascular inflammation and atherosclerosis. Circulation 120:699–708. https://doi.org/10.1161/CIRCULATIONAHA.108.806547
Article
PubMed
CAS
Google Scholar
Pålsson-McDermott EM, O’Neill LAJ (2004) Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 113:153–162. https://doi.org/10.1111/j.1365-2567.2004.01976.x
Article
PubMed
PubMed Central
CAS
Google Scholar
Pucci S, Fisco T, Zonetti MJ, Bonanno E, Mazzarelli P, Mauriello A (2014) PTX3: a modulator of human coronary plaque vulnerability acting by macrophages type 2. Int J Cardiol 176:710–717. https://doi.org/10.1016/j.ijcard.2014.07.109
Article
PubMed
CAS
Google Scholar
Rolph MS, Zimmer S, Bottazzi B, Garlanda C, Mantovani A, Hansson GK (2002) Production of the long pentraxin PTX3 in advanced atherosclerotic plaques. Arter Thromb Vasc Biol 22:10–14. https://doi.org/10.1161/01.ATV.0000015595.95497.2F
Article
Google Scholar
Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116:3015–3025. https://doi.org/10.1172/JCI28898
Article
PubMed
PubMed Central
CAS
Google Scholar
Shiraki A, Kotooka N, Komoda H, Hirase T, Oyama J, Node K (2016) Pentraxin-3 regulates the inflammatory activity of macrophages. Biochem Biophys Reports 5:290–295. https://doi.org/10.1016/j.bbrep.2016.01.009
Article
Google Scholar
Sindhu S, Al-Roub A, Koshy M, Thomas R, Ahmad R (2016) Palmitate-induced MMP-9 expression in the human monocytic cells is mediated through the TLR4-MyD88 dependent mechanism. Cell Physiol Biochem 39:889–900. https://doi.org/10.1159/000447798
Article
PubMed
CAS
Google Scholar
Slusher AL, Huang C-J (2016) Association of pentraxin 3 with insulin resistance and glucose response following maximal aerobic exercise in obese and normal-mass individuals. Can J Physiol Pharmacol 94:734–738. https://doi.org/10.1139/cjpp-2015-0464
Article
PubMed
CAS
Google Scholar
Slusher AL, Mock JT, Whitehurst M, Maharaj A, Huang CJ (2015) The impact of obesity on pentraxin 3 and inflammatory milieu to acute aerobic exercise. Metabolism 64:323–329. https://doi.org/10.1016/j.metabol.2014.10.022
Article
PubMed
CAS
Google Scholar
Slusher AL, Mischo AB, Acevedo EO (2016) Pentraxin 3 is an anti-inflammatory protein associated with lipid-induced interleukin 10 in vitro. Cytokine 86:36–40. https://doi.org/10.1016/j.cyto.2016.07.012
Article
PubMed
CAS
Google Scholar
Slusher AL, Shibata Y, Whitehurst M, Maharaj A, Quiles JM, Huang C-J (2017) Exercise reduced pentraxin 3 levels produced by endotoxin-stimulated human peripheral blood mononuclear cells in obese individuals. Exp Biol Med 242:1279–1286. https://doi.org/10.1177/1535370217706963
Article
CAS
Google Scholar
Slusher AL, Zúñiga TM, Acevedo EO (2018) Maximal exercise alters the inflammatory phenotype and response of mononuclear cells. Med Sci Sports Med 50:675–683. https://doi.org/10.1249/MSS.0000000000001480
Article
Google Scholar
Steensberg A, Fischer CP, Keller C, Møller K, Pedersen BK (2003) IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am J Physiol Endocrinol Metab 285:E433-437. https://doi.org/10.1152/ajpendo.00074.2003
Article
Google Scholar
Sun H, Tian J, Xian W, Xie T, Yang X (2015) Pentraxin-3 attenuates renal damage in diabetic nephropathy by promoting M2 macrophage differentiation. Inflammation 38:1739–1747. https://doi.org/10.1007/s10753-015-0151-z
Article
PubMed
CAS
Google Scholar
Van Gaal LF, Mertens IL, De Block CE (2006) Mechanisms linking obesity with cardiovascular disease. Nature 444:875–880. https://doi.org/10.1038/nature05487
Article
PubMed
CAS
Google Scholar
Weiss EP, Reeds DN, Ezekiel UR, Albert SG, Villareal DT (2017) Circulating cytokines as determinants of weight loss-induced improvements in insulin sensitivity. Endocrine 55:153–164. https://doi.org/10.1007/s12020-016-1093-4
Article
PubMed
CAS
Google Scholar
Yang HS, Woo JE, Lee SJ, Park SH, Woo JM (2014) Elevated plasma pentraxin 3 levels are associated with development and progression of diabetic retinopathy in Korean patients with type 2 diabetes mellitus. Invest Ophthalmol Vis Sci 55:5989–5997. https://doi.org/10.1167/iovs.14-14864
Article
PubMed
CAS
Google Scholar
Zempo-Miyaki A, Fujie S, Sato K, Hasegawa N, Sanada K, Maeda S, Hamaoka T, Iemitsu M (2016) Elevated pentraxin 3 level at the early stage of exercise training is associated with reduction of arterial stiffness in middle-aged and older adults. J Hum Hypertens 30:521–526. https://doi.org/10.1038/jhh.2015.105
Article
PubMed
CAS
Google Scholar